Jane Street Group, LLC Zymeworks Inc. Call Options Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 15, 2022	SELL	$15.19 - $29.33 $215,698 - $416,486	-14,200 Reduced 33.18%	28,600 $469,000
Q2 2021 Aug 16, 2021	SELL	$26.5 - $38.23 $826,800 - $1.19 Million	-31,200 Reduced 42.16%	42,800 $1.49 Million
Q1 2021 May 18, 2021	BUY	$29.83 - $56.81 $701,005 - $1.34 Million	23,500 Added 46.53%	74,000 $2.34 Million
Q4 2020 Feb 17, 2021	SELL	$39.12 - $54.99 $140,832 - $197,964	-3,600 Reduced 6.65%	50,500 $2.39 Million
Q3 2020 Nov 17, 2020	BUY	$29.21 - $46.58 $245,364 - $391,272	8,400 Added 18.38%	54,100 $2.52 Million
Q2 2020 Aug 17, 2020	BUY	$33.67 - $40.0 $1.54 Million - $1.83 Million	45,700 New	45,700 $1.65 Million

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $856M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.